Target intelligence / Profile preview

Staphylococcus cell wall

Molecular classification
Complex macromolecule, Peptidoglycan, Teichoic acid, Polysaccharide
01

Overview

The Staphylococcus cell wall is a robust, multi-layered structure essential for bacterial survival, primarily composed of a thick peptidoglycan layer (up to 50% of cell mass) and secondary polymers like wall teichoic acids (WTA) (Swoboda et al., 2010, ChemBioChem). Its fundamental biological role is to maintain cell shape and provide osmotic stability, preventing lysis under high internal pressure (Silhavy et al., 2010, Cold Spring Harbor Perspectives in Biology). Beyond structural support, the cell wall serves as a scaffold for surface proteins (MSCRAMMs) that facilitate adhesion to host tissues and evasion of the immune system during infections (Foster et al., 2014, Nature Reviews Microbiology). Clinically, it is a premier therapeutic target; beta-lactam antibiotics inhibit the transpeptidase enzymes (penicillin-binding proteins) that cross-link peptidoglycan, while glycopeptides like vancomycin bind directly to the D-Ala-D-Ala terminus of precursors to block polymerization (Kohanski et al., 2010, Nature Reviews Microbiology). The evolution of the cell wall—specifically the acquisition of the mecA gene encoding PBP2a—is the primary driver of methicillin resistance (MRSA), making it a focal point of global infectious disease research (Fishovitz et al., 2014, IUBMB Life).

Other names
Staphylococcal cell wallPeptidoglycan layerGram-positive cell wallBacterial cell envelope
02

Mechanism of action

Inhibition of peptidoglycan biosynthesis by binding to penicillin-binding proteins (PBPs) to prevent transpeptidation, or by binding to the D-alanyl-D-alanine terminus of cell wall precursors to inhibit polymerization and cross-linking.

03

Biological functions

Structural integrityOsmotic protectionCell divisionAdhesionImmune evasionVirulence factor anchoring
04

Disease associations

InfectionSepsisBacteremiaEndocarditisPneumoniaSkin and soft tissue infection
05

Safety considerations

Antibiotic resistance (MRSA, VRSA)Hypersensitivity and anaphylaxisNephrotoxicityOtotoxicityRed man syndromeDisruption of host microbiome
06

Interacting drugs

Vancomycin

9 more in the full profile.

07

Biomarkers

mecA gene (MRSA detection)PBP2a protein expressionVancomycin Minimum Inhibitory Concentration (MIC)Wall teichoic acid (WTA) levels

Beyond the preview

Go deeper on Staphylococcus cell wall.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcus cell wall.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call